| |
| |
|
| Insider
Information: |
Good Jennifer L |
| Relationship: |
See Remarks, Director,... |
| City: |
Danbury |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
206,204 |
|
|
Indirect Shares
|
18,034 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
224,238 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Penwest Pharmaceuticals Co |
PPCO |
President & CEO |
2010-09-20 |
0 |
2010-04-28 |
18,034 |
Premium* |
|
|
Juniper Pharmaceuticals Inc |
JNP |
Director |
2018-08-14 |
0 |
2017-09-07 |
0 |
Premium* |
|
|
Trevi Therapeutics, Inc. |
TRVI |
See Remarks, Director,... |
2019-05-09 |
206,204 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TRVI |
Trevi Therapeutics, Inc. |
See Remarks |
• • • |
2019-05-09 |
4 |
B |
$10.00 |
$112,500 |
D/D |
11,250 |
206,204 |
3.23 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
See Remarks |
• • • |
2019-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
18,348 |
194,954 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
See RemarksOfficer |
• • • |
2019-05-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
176,606 |
|
- |
|
| JNP |
Juniper Pharmaceuticals I... |
Director |
– • – |
2018-08-14 |
4 |
D |
$11.50 |
$172,500 |
D/D |
(15,000) |
0 |
0 |
- |
|
| JNP |
Juniper Pharmaceuticals I... |
Director |
– • – |
2017-09-07 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
President & CEO |
• – – |
2010-09-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(60,994) |
0 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
President & CEO |
• • – |
2010-04-28 |
4 |
OE |
$1.56 |
$39,000 |
D/D |
25,000 |
42,960 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
President & CEO |
• • – |
2009-11-11 |
4 |
B |
$2.14 |
$16,050 |
D/D |
7,500 |
17,369 |
2.81 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
officerTitle |
• – – |
2005-12-02 |
4 |
S |
$18.02 |
$356,000 |
D/D |
(19,758) |
5,867 |
|
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
officerTitle |
• – – |
2005-12-02 |
4 |
OE |
$5.41 |
$96,071 |
D/D |
17,758 |
25,625 |
|
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Chief Financial Officer |
• – – |
2005-10-03 |
4 |
S |
$18.00 |
$9,000 |
D/D |
(500) |
7,867 |
|
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Chief Financial Officer |
• – – |
2005-10-03 |
4 |
OE |
$5.41 |
$2,705 |
D/D |
500 |
8,367 |
|
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Chief Financial Officer |
• – – |
2005-09-07 |
4 |
S |
$15.98 |
$210,586 |
D/D |
(13,180) |
7,867 |
|
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Chief Financial Officer |
• – – |
2005-09-07 |
4 |
OE |
$7.57 |
$99,773 |
D/D |
13,180 |
21,047 |
|
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Chief Financial Officer |
• – – |
2005-08-22 |
4 |
S |
$12.76 |
$79,443 |
D/D |
(6,226) |
7,867 |
|
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Chief Financial Officer |
• – – |
2005-08-22 |
4 |
OE |
$7.57 |
$47,131 |
D/D |
6,226 |
14,093 |
|
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Chief Financial Officer |
• – – |
2005-03-24 |
4 |
OE |
$5.41 |
$10,820 |
D/D |
2,000 |
7,867 |
|
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Chief Financial Officer |
• – – |
2004-02-23 |
4 |
OE |
$5.41 |
$10,820 |
D/D |
2,000 |
5,240 |
|
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Chief Financial Officer |
• – – |
2003-12-02 |
4 |
OE |
$5.41 |
$10,820 |
D/D |
2,000 |
2,950 |
|
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Chief Financial Officer |
• – – |
2003-09-11 |
4 |
S |
$20.93 |
$270,856 |
D/D |
(12,938) |
0 |
|
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Chief Financial Officer |
• – – |
2003-09-11 |
4 |
OE |
$6.22 |
$80,474 |
D/D |
12,938 |
12,938 |
|
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
